Related Experiment Video
Updated: Sep 20, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Surgical and radiological management of renovascular hypertension in a developing country
Anant Kumar1, Deepak Dubey, Pradeep Bansal
1Department of Urology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Rae Bareli Road, Lucknow, India. anant@sgpgi.ac.in
Insights
Both percutaneous transluminal angioplasty and surgical revascularization offer comparable long-term outcomes for renovascular hypertension caused by renal artery stenosis in young patients. Angioplasty shows higher re-stenosis rates in Takayasu
Area of Science:
- Cardiovascular Medicine
- Interventional Radiology
- Pediatric Hypertension
Background:
- Renovascular hypertension in young patients is often caused by Takayasu's arteritis (TA) or fibromuscular dysplasia (FMD).
- Long-term outcomes of interventions for renal artery stenosis in this demographic require further elucidation.
Purpose of the Study:
- To compare the long-term efficacy of radiological (percutaneous transluminal angioplasty) and surgical interventions for renovascular hypertension in young patients.
- To evaluate technical success, complications, and clinical response rates for both treatment modalities.
Main Methods:
- Retrospective analysis of 85 young patients (mean age 21 years) with renovascular hypertension due to TA (n=59) or FMD (n=26) between 1989 and 2001.
- Comparison of outcomes following percutaneous transluminal angioplasty (n=49) and surgical procedures (n=41).
Main Results:
- Technical success for angioplasty was 94.58%, with an 83.9% clinical response rate. Re-stenosis rates were 24.13% for TA and 10% for FMD.
- Surgical revascularization procedures achieved a 94.4% clinical response rate, while nephrectomy/partial nephrectomy had a 50% response rate.
- Median follow-up was 42 months, with surgery demonstrating comparable long-term results to angioplasty.
Conclusions:
- Percutaneous transluminal angioplasty and surgical revascularization yield similar long-term results for managing renal artery stenosis in TA and FMD.
- Surgery for TA is safe and effective despite technical complexity, with lower re-stenosis rates compared to angioplasty in TA.
- Angioplasty is a viable option, but higher re-stenosis rates in TA warrant consideration.
Purpose:
We determined the long-term outcome of radiological and surgical intervention in young patients with renovascular hypertension.
Materials And Methods:
Between 1989 and 2001, 85 patients with a mean age +/- SD of 21 +/- 10.3 years, including 59 with Takayasu's arteritis (TA) and 26 with fibromuscular dysplasia (FMD), underwent radiological (percutaneous transluminal angioplasty) or surgical treatment for renovascular hypertension due to renal artery stenosis. The technical success, complications and clinical response of each treatment were compared.
Results:
Of the patients 29 with TA and 20 with FMD underwent a total of 56 balloon angioplasties. Technical success was achieved in 94.58 renal units with a clinical response in 41 patients (83.9%). However, the re-stenosis rate was 24.13% in TA and 10% in FMD cases. A total of 41 surgical procedures were performed in the 28 and 7 patients with TA and FMD, respectively, including aortorenal bypass with vein in 12, and with a polytetrafluoroethylene graft in 4, lienorenal bypass in 4, iliorenal bypass in 2, gastroduodenal bypass in 1, autotransplantation in 1, nephrectomy in 14 and partial nephrectomy in 2. The clinical response rate to renal revascularization procedures was 94.4%, whereas it was only 50.0% for nephrectomy/partial nephrectomy during a median followup of 42 months (range 9 to 96).
Conclusions:
Percutaneous transluminal angioplasty and renal revascularization provide comparable long-term results in the management of renal artery stenosis due to TA and FMD. Although it is technically complex, surgery for TA is safe and effective. However, the rate of re-stenosis following angioplasty for TA is higher compared with FMD.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Chronic Kidney Disease III: Interprofessional Care
Hypertension V: Nursing Management
Urinary Tract Calculi VI: Surgical Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Aneurysm III: Interprofessional Care

